Resources
AVAC’s Resource Database contains educational and advocacy materials covering a wide range of issues on biomedical prevention of HIV, STIs, COVID-19 and emerging health threats—from research to rollout.
To search for clinical trials and detailed information on products in development, visit our Prevention Research & Development Database
Results
showing 1-10 of 810
Unpacking Cure at CROI: A Q&A with Jessica Salzwedel
AVAC’s Jessica Salzwedel, leader of our HIV cure research advocacy, shares her highlights from the research presented at CROI 2024 and insights into what this means for advocacy in this Q&A.
Prevention Option:
Wednesday’s CROI Update
The presentations on the last day of CROI 2024 highlighted yet again that research conducted in ethical partnership with communities is about developing products and delivering them with speed, scale, equity and impact.
Tuesday’s CROI Roundup
Yesterday’s second full day at CROI 2024 in Denver included several studies presented on biomedical prevention, and the sum total of the message is clear: PrEP works, and choice works! Whether we’re talking about a daily pill of PrEP, injectable cabotegravir, or the dapivirine vaginal ring, from the US to Kenya, Australia to Uganda, people deserve choice!
CROI Roundup – Highlights from Monday
The highs and lows of great science but profound inequities were front and center on the first official day of CROI 2024.
HIV Vaccine and Antibody Efficacy Trials to Date
This infographic provides a comprehensive overview of HIV vaccine and antibody efficacy trials. Over 20 years and 12 trials, only two positive signals have been observed.
Prevention Option:
PxWire Volume 14, Issue No. 1
PxWire is AVAC’s quarterly update covering the latest in the field of biomedical HIV prevention research and development, implementation and advocacy. Each issue includes updates, emerging issues and upcoming events.
Prevention Option:
New Product Introduction Update
As of January 2024, 17 studies are ongoing. Ten other studies await supplies of injectable CAB, expected in the first half of 2024.
Cumulative PrEP Initiations
In 2020, the world missed the UNAIDS’ goal of reaching 3 million PrEP users. The updated target for 2025 is 10 million. Is the 2025 target achievable based on the current trends in PrEP uptake?
Prevention Option:
Join us for CROI 2024!
AVAC and partners have worked to follow and explain the research presented at CROI for many years, making the science more accessible, connecting the findings to community priorities, and ensuring civil society and affected communities are represented within the program, and ultimately the research.
AVAC Condemns Ghana’s Actions to Further Criminalize LGBTQ+ People
AVAC joins allies around the world to condemn in the strongest possible terms this week’s actions by Ghana’s lawmakers, who have passed legislation to further criminalize LGBTQ+ people.
showing 1-10 of 810